Litigation Details for HELSINN HEALTHCARE S.A. v. ACTAVIS LLC (D.N.J. 2016)
✉ Email this page to a colleague
HELSINN HEALTHCARE S.A. v. ACTAVIS LLC (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-03-24 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-05-15 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 7,947,724; 9,066,980 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in HELSINN HEALTHCARE S.A. v. ACTAVIS LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for HELSINN HEALTHCARE S.A. v. ACTAVIS LLC (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-03-24 | 1 | of United States Patent No. 7,947,724 (“the ’724 patent”) and United States Patent No. 9,066,980 (“the…“the ’980 patent”). This action arises under the patent laws of the United States, 35 U.S.C. §§ 100 et… THE PATENTS-IN-SUIT 10. On May 24, 2011, the ’724 patent, titled “Liquid… ’724 patent is attached as Exhibit A. 11. On June 30, 2015, the ’980 patent, titled…Pursuant to 21 U.S.C. § 355(b)(l), the ’724 patent and the ’980 patent are listed in the United States Food | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
